Literature DB >> 22026527

Synthetic cannabinoid exposures reported to Texas poison centers.

Mathias B Forrester1, Kurt Kleinschmidt, Evan Schwarz, Amy Young.   

Abstract

Synthetic cannabinoid abuse is increasing in the United States. Synthetic cannabinoid exposures reported to Texas poison centers in 2010 were identified, and the distribution of exposures by selected factors was determined. There were 464 total cases. The number of exposures increased each month during January-July, then remained relatively constant for the next 5 months. The patients were 73.9% male and 57.3% were 20 years or older. Moderate or major effects or potentially toxic outcome occurred in 59.9% of the exposures. The most frequently reported clinical effects were tachycardia (37.3%), agitation (18.5%), drowsiness (18.5%), vomiting (15.7%), hallucinations (10.8%), and nausea (9.9%).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22026527     DOI: 10.1080/10550887.2011.609807

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  20 in total

1.  Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs.

Authors:  Megan Grabenauer; Wojciech L Krol; Jenny L Wiley; Brian F Thomas
Journal:  Anal Chem       Date:  2012-06-20       Impact factor: 6.986

Review 2.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

Review 3.  Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Authors:  Kathryn A Seely; Jeff Lapoint; Jeffery H Moran; Liana Fattore
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-26       Impact factor: 5.067

4.  CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.

Authors:  Niels Bjerre Holm; Line Marie Nielsen; Kristian Linnet
Journal:  AAPS J       Date:  2015-05-23       Impact factor: 4.009

5.  Bilateral multiple exudative retinal detachments and macular edema in a patient diagnosed with synthetic cannabinoid (Bonzai) intoxication.

Authors:  Ahmet Kırgız; Havva Kaldırım
Journal:  Int Ophthalmol       Date:  2017-12-23       Impact factor: 2.031

6.  Atypical diabetic ketoacidosis: case report.

Authors:  Hüseyin Demirci; Ramazan Coşar; Özcan Çiftçi; Işılay Kalan Sarı
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

7.  Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Authors:  Francois R Lamy; Raminta Daniulaityte; Ramzi W Nahhas; Monica J Barratt; Alan G Smith; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2017-06-01

Review 8.  The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective.

Authors:  Laura Orsolini; Stefania Chiappini; Duccio Papanti; Domenico De Berardis; John M Corkery; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2019-11-20       Impact factor: 4.157

Review 9.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

Review 10.  What is the Current Knowledge About the Cardiovascular Risk for Users of Cannabis-Based Products? A Systematic Review.

Authors:  Emilie Jouanjus; Valentin Raymond; Maryse Lapeyre-Mestre; Valérie Wolff
Journal:  Curr Atheroscler Rep       Date:  2017-06       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.